Related Experiment Video
Updated: Aug 9, 2026

08:51
The Use of Thermal Infra-Red Imaging to Detect Delayed Onset Muscle Soreness
Published on: January 22, 2012
Effect of microcurrent stimulation on delayed-onset muscle soreness: a double-blind comparison
J D Allen1, C G Mattacola, D H Perrin
1Purdue University, Lafayette, IN.
Journal of Athletic Training
|March 25, 2006
Summary
Microcurrent electrical neuromuscular stimulation (MENS) did not effectively reduce pain or improve range of motion for delayed-onset muscle soreness (DOMS) in this study. The MENS group showed no significant difference compared to the sham group.
Area of Science:
- Sports Medicine
- Rehabilitation Science
- Physical Therapy
Background:
- Delayed-onset muscle soreness (DOMS) is a common condition resulting from strenuous exercise, causing pain and reduced range of motion (ROM).
- Microcurrent electrical neuromuscular stimulation (MENS) is a therapeutic modality used to manage pain and improve function.
- The efficacy of MENS for DOMS-related symptoms requires further investigation.
Purpose of the Study:
- To evaluate the effectiveness of MENS treatment in alleviating pain and restoring ROM in individuals experiencing DOMS.
- To compare the outcomes of MENS treatment against a sham treatment in a controlled study.
Main Methods:
- Eighteen subjects with induced DOMS in the biceps brachii were randomly assigned to either a MENS group or a sham group.
- The MENS group received a specific MENS protocol (200 μA, 30 Hz for 10 min, then 100 μA, 0.3 Hz for 10 min) at 24, 48, and 72 hours post-induction.
- Pain was assessed using a graphic rating scale and ROM via goniometry, with measurements taken before and after each treatment session.
Main Results:
- No statistically significant differences were observed in subjective pain scores between the MENS and sham groups.
- Active elbow extension range of motion (ROM) did not show significant improvement in the MENS group compared to the sham group.
- The study found no discernible benefit of MENS over sham treatment for the measured outcomes of pain and ROM in DOMS.
Conclusions:
- The MENS treatment, under the specific parameters utilized in this study, did not demonstrate efficacy in reducing pain associated with DOMS.
- The application of MENS did not lead to a significant improvement in range of motion for individuals suffering from delayed-onset muscle soreness.
- Further research may be needed to explore different MENS parameters or alternative therapeutic approaches for managing DOMS symptoms.

